CERo Therapeutics Holdings, Inc. (NASDAQ:CEROW) Short Interest Down 54.0% in March

CERo Therapeutics Holdings, Inc. (NASDAQ:CEROW) saw a large drop in short interest in the month of March. As of March 15th, there was short interest totalling 16,900 shares, a drop of 54.0% from the February 28th total of 36,700 shares. Based on an average daily trading volume, of 107,500 shares, the short-interest ratio is currently 0.2 days.

CERo Therapeutics Stock Performance

NASDAQ CEROW traded down $0.00 on Friday, reaching $0.01. The stock had a trading volume of 43,054 shares, compared to its average volume of 90,879. CERo Therapeutics has a 1 year low of $0.00 and a 1 year high of $0.13. The business has a 50 day moving average price of $0.01 and a 200 day moving average price of $0.01.

About CERo Therapeutics

CERo Therapeutics Holdings, Inc, an immunotherapy company, focuses on advancing the development of engineered T cell therapeutics for the treatment of cancer. Its lead development candidate is CER-1236, an autologous T cell therapy candidate for the treatment of hematologic malignancies. The company was incorporated in 2021 and is based in South San Francisco, California.